Document is current
Any future updates will be listed below
-
Authors
Kendler, David L. https://orcid.org/0000-0001-7679-3965
Habert, Jeffrey
Khan, Aliya A.
Kherani, Raheem B.
Kim, Sandra
Kovacs, Christopher S.
Lee, Jooho
Purvis, Jane
Reis, Jodie
Slatkovska, Lubomira
Thain, Jenny
Adachi, Jonathan D.
- License Information
-
More Information
Article History
Received: 8 December 2025
Accepted: 16 January 2026
First Online: 17 February 2026
Declarations
:
: DLK: consultant, advisory board and/or speaker honoraria from ZP Pharma, Amgen and Sandoz. JH: consultant, advisory board member and/or speaker for Boehringer, Eli-Lilly, Elvium, Bausch, AstraZeneca, Novartis, Lundbeck, Novo-Nordisk, Janssen, Eisai, HLS, Otsuka, Idorsia Pfizer, Amgen, Abbvie, GSK, and Bayer. AAK: honoraria from Amgen and research grants from Ascendis, AstraZeneca, Bidgebio, and Takeda. SK: no financial disclosures with commercial or industry entities; serves on the Scientific Advisory Council for Osteoporosis Canada as a volunteer member. CSK: advisory board honoraria from Amgen, Ipsen, Kyowa Kirin, and Pendopharm. JL: advisory board and speaker honoraria, and research grants from Amgen. JP: no financial disclosures with commercial or industry entities. JR: advisory board and/or speaker honoraria from Amgen. LS: consultant for Amgen. JT: advisory board and/or speaker honoraria from Amgen and Kyowa Kirin; research grants from Amgen; and employed as the Clinical Lead for Hip Fracture by Ontario Health. JDA: advisory board and/or speaker honoraria from Alexion, Amgen, Organon, and Sandoz; research grants from Canadian Institutes of Health Research; and advisor for Osteoporosis Canada.
